Top Stories

An RBC-run sale process kicks off for the CDMO, which specializes in the lyophilization of drugs and devices.

Proving a testament to the nation's growing demand for behavioral health services, exiting investors Lee Equity and FFL Partners are each poised to make 4x their money with the sale, sources say.

PE-backed strategics and sponsors submitted initial bids last week for TransUnion Healthcare, with at least one party bidding as high as $1.6bn in the first round, sources told PE Hub.

French-born Astorg is on track to grow its New York investment roster by the end of 2022 to some 15 to 20 team members focused on US healthcare and software investing, sources told PE Hub.

The PE-backed legal-tech platform builds out its offerings with yet another acquisition.

Using the playbook that guided 3i's formation of bioprocessing platform SaniSure, the firm believes the best way to achieve its latest vision is by building it.

Fresh on the heels of Cerberus' $400m-plus deal for Lighthouse Autism, the heightened valuations achieved in the two transactions reflect investors belief in the growth of the autism-treatment industry.

As a persistent nurse shortage problem fuels increasing demand for MedSol’s services, the ability to use technology to help systems manage their own labor force is another growth driver for the healthcare staffing provider.

Under Linden's six-year-plus hold, the CDMO grew its capabilities and added facilities with the acquisition of two Salt Lake City-based companies while recruiting several seasoned executives to the C-suite.

The Chicago sponsor inks its second deal in the insurance claims arena, winning a Lazard-run sale process.